Optimal dose for topical use of tranexamic acid after cardiovascular surgery
Not Applicable
Withdrawn
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0004211
- Lead Sponsor
- Korea University Anam Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- All
- Target Recruitment
- 123
Inclusion Criteria
An adult who has been operated on for heart and aortic disease
-Men and women aged 19 and over
-Those who voluntarily agree to this study
Exclusion Criteria
-In case of preoperative antifibrinolytics used
-In case who was diagnosed with preoperative blood clot disease
-In case of liver cirrhosis
-Patients with thrombotic thrombosis and such a history
-Patients who overreact to this drug and its constituent parts
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding flow (verified by blood test)
- Secondary Outcome Measures
Name Time Method Blood transfusion flow;arterial blood gas analysis;Chest tube drainage;Cardiac ultrasonography;surgical complication;Survival status